Chronic pain

News

Vertex Pharma chief executive Reshma Kewalramani

Vertex is smarting from a pain portfolio setback

Shares in Vertex Pharma have come under pressure after one of its non-opioid pain candidates failed to move the needle in a mid-stage trial.

News

Vertanical's chief executive, Dr Clemens Fischer

Vertanical's cannabis-based painkiller hits target in trials

A cannabis-derived drug developed by Vertanical has shown efficacy in phase 3 for chronic back pain and could reach its first markets soon.

News

Newel's VR therapy for chronic pain nears EU market

Newel Health has been granted EU certification for its VR-based digital therapeutic for chronic pain, clearing the way for its launch in Europe.

News

Pin cushion doll representing pain points in a person

Algiax non-opioid drug works in chronic neuropathic pain

A GABA-targeting drug developed by German Biotech Algiax has shown proof of concept in a chronic neuropathic trial trial.

News

Tris cues up filing for non-opioid pain drug on phase 3 win

Tris Pharma has set its sights on an FDA filing for non-opioid pain drug cebranopadol this year after hitting the mark in an abdominoplasty trial.

News

Levicept says non-opioid drug cuts arthritis pain in phase 2

A non-opioid drug for pain developed by UK biotech Levicept, with a new mechanism of action, has shown it can reduce pain associated with osteoarthritis in a phase 2 trial.

Vertex is smarting from a pain portfolio setback

Vertanical's cannabis-based painkiller hits target in trials

Newel's VR therapy for chronic pain nears EU market

Algiax non-opioid drug works in chronic neuropathic pain

Tris cues up filing for non-opioid pain drug on phase 3 win

Levicept says non-opioid drug cuts arthritis pain in phase 2

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Chronic pain

Editor's Picks